Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Cannabis Bioscience International Holdings, Inc.

Get SEC filing alerts via email and in your feed for Cannabis Bioscience International Holdings, Inc.

CBIH

Cannabis Bioscience International Holdings, Inc.

About Cannabis Bioscience International Holdings, Inc.

Cannabis Bioscience International Holdings develops research, education, and clinical trial services focused on medicinal cannabis and CBD products. It offers scientific research, professional training, and digital educational materials to industry professionals, patients, and regulators. The company plans to commercialize CBD edibles under VitaCookies and conducts cannabinoid clinical trials. Its core value lies in advancing biotech and scientific understanding of cannabis for medical applications.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Cannabis Bioscience International Holdings, Inc.

1
1
Cannabis Bioscience International Holdings, Inc. Cannabis Bioscience Reports Revenue Decline and Increased Net Losses for Quarter Ending February 28, 2026

Via official filing (AI summary) | about 2 months ago | 0 comments

2
1
Cannabis Bioscience International Holdings, Inc. Cannabis Bioscience International Holdings Reports 28.2% Revenue Decline and Increased Losses for Quarter Ending November 30, 2025

Via official filing (AI summary) | 4 months ago | 0 comments

3
1
Cannabis Bioscience International Holdings, Inc. Cannabis Bioscience Reports 86% Revenue Decline and Increased Net Loss for Quarter Ending August 31, 2025

Via official filing (AI summary) | 8 months ago | 0 comments

4
1
Cannabis Bioscience International Holdings, Inc. Cannabis Bioscience International Holdings Reports 21.7% Revenue Increase for Fiscal Year Ending May 31, 2025

Via official filing (AI summary) | 9 months ago | 0 comments

5
1
Cannabis Bioscience International Holdings, Inc. Cannabis Bioscience International Holdings Reports Revenue Decline and Increased Net Loss for Quarter Ended February 28, 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Cannabis Bioscience International Holdings, Inc. Cannabis Bioscience International Holdings Reports Revenue Growth Amid Ongoing Financial Challenges

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
Cannabis Bioscience International Holdings, Inc. Cannabis Bioscience International Holdings Reports Significant Revenue Growth and Reduced Losses in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments